BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24166212)

  • 1. Could the complement component C4 or its fragment C4d be a marker of the more severe conditions in patients with primary Sjögren's syndrome?
    Sudzius G; Mieliauskaite D; Siaurys A; Viliene R; Butrimiene I; Characiejus D; Dumalakiene I
    Rheumatol Int; 2014 Feb; 34(2):235-41. PubMed ID: 24166212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of salivary and serum-free light chain assays in primary Sjögren's syndrome: a pilot study.
    Sandhya P; Christudoss P; Kabeerdoss J; Mandal SK; Aithala R; Mahasampath G; Job V; Danda D
    Int J Rheum Dis; 2017 Jun; 20(6):760-766. PubMed ID: 28036132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.
    Gottenberg JE; Aucouturier F; Goetz J; Sordet C; Jahn I; Busson M; Cayuela JM; Sibilia J; Mariette X
    Ann Rheum Dis; 2007 Jan; 66(1):23-7. PubMed ID: 16569685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of BAFF and IL-17A with subphenotypes of primary Sjögren's syndrome.
    Deng F; Chen J; Zheng J; Chen Y; Huang R; Yin J; Gao X; Lin Q; Huang C; Gao Y; Yu X; Liu Z
    Int J Rheum Dis; 2016 Jul; 19(7):715-20. PubMed ID: 25941062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome.
    Sanosyan A; Daien C; Nutz A; Bollore K; Bedin AS; Morel J; Zimmermann V; Nocturne G; Peries M; Guigue N; Gottenberg JE; Van de Perre P; Mariette X; Tuaillon E
    Front Immunol; 2019; 10():1153. PubMed ID: 31191532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.
    Corominas H; Ortiz-Santamaría V; Castellví I; Moreno M; Morlà R; Clavaguera T; Erra A; Martínez-Pardo S; Ordóñez S; Santo P; Reyner P; González MJ; Codina O; Gelman MS; Juanola-Roura X; Olivé A; Torrente-Segarra V;
    Rheumatol Int; 2016 Mar; 36(3):365-9. PubMed ID: 26597492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement inhibitor C4b-binding protein in primary Sjögren's syndrome and its association with other disease markers.
    Zadura AF; Theander E; Blom AM; Trouw LA
    Scand J Immunol; 2009 Apr; 69(4):374-80. PubMed ID: 19284503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren's syndrome.
    Traianos EY; Locke J; Lendrem D; Bowman S; Hargreaves B; Macrae V; ; Tarn JR; Ng WF
    Rheumatol Int; 2020 Apr; 40(4):541-548. PubMed ID: 32047959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBV reactivation serological profile in primary Sjögren's syndrome: an underlying trigger of active articular involvement?
    Pasoto SG; Natalino RR; Chakkour HP; Viana Vdos S; Bueno C; Leon EP; Vendramini MB; Neto ML; Bonfa E
    Rheumatol Int; 2013 May; 33(5):1149-57. PubMed ID: 22955798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
    Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
    Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of interleukin-34 and clinical correlation in patients with primary Sjögren's syndrome.
    Liu Y; Zhang B; Lei Y; Xia L; Lu J; Shen H
    Int J Rheum Dis; 2020 Mar; 23(3):374-380. PubMed ID: 31823505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome.
    Gottenberg JE; Busson M; Cohen-Solal J; Lavie F; Abbed K; Kimberly RP; Sibilia J; Mariette X
    Ann Rheum Dis; 2005 Jul; 64(7):1050-5. PubMed ID: 15640273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The application of combined detection of autoantibodies in primary Sjögren's syndrome].
    He J; Fang W; Li ZG
    Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):366-8. PubMed ID: 18953942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome.
    Liang Y; Xian Z; Fu D; Liu S; Yao Y; Jin Y; Gao C; Shen L; Shi G; He J
    Front Immunol; 2021; 12():673658. PubMed ID: 34012457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperviscosity in primary Sjögren's syndrome: clinical implications.
    Hernández-Molina G; Bermúdez-Bermejo P
    Int J Rheum Dis; 2017 Jan; 20(1):84-89. PubMed ID: 26807556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
    Chen C; Liang Y; Zhang Z; Zhang Z; Yang Z
    Int Immunopharmacol; 2020 Nov; 88():106878. PubMed ID: 32791244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibody to MDM2: A potential serological marker of primary Sjogren's syndrome.
    Liu Y; Liao X; Wang Y; Chen S; Sun Y; Lin Q; Shi G
    Oncotarget; 2017 Feb; 8(9):14306-14313. PubMed ID: 28147328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and potential relevant factors of renal involvement in primary Sjögren's syndrome.
    Luo J; Xu S; Lv Y; Huang X; Zhang H; Zhu X; Wang X
    Int J Rheum Dis; 2019 Feb; 22(2):182-190. PubMed ID: 30411528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum immunoglobulin free light chains are sensitive biomarkers for monitoring disease activity and treatment response in primary Sjögren's syndrome.
    Verstappen GM; Moerman RV; van Nimwegen JF; van Ginkel MS; Bijzet J; Mossel E; Vissink A; Hazenberg BPC; Arends S; Kroese FGM; Bootsma H
    Rheumatology (Oxford); 2018 Oct; 57(10):1812-1821. PubMed ID: 29982712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.